Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 5
2012 2
2013 2
2014 2
2015 5
2016 2
2017 6
2018 10
2019 4
2020 9
2021 11
2022 5
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for brian betts
Search for Brian Butts instead (2 results)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology.
Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Hill GR, et al. Among authors: betts bc. Annu Rev Immunol. 2021 Apr 26;39:19-49. doi: 10.1146/annurev-immunol-102119-073227. Epub 2021 Jan 11. Annu Rev Immunol. 2021. PMID: 33428454 Free PMC article.
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Boucher JC, Shrestha B, Vishwasrao P, Leick M, Cervantes EV, Ghafoor T, Reid K, Spitler K, Yu B, Betts BC, Guevara-Patino JA, Maus MV, Davila ML. Boucher JC, et al. Among authors: betts bc. Mol Ther Oncolytics. 2023 Nov 20;31:100751. doi: 10.1016/j.omto.2023.100751. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38075241 Free PMC article.
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.
Holtan SG, Savid-Frontera C, Walton K, Eaton AA, Demorest C, Hoeschen A, Zhang L, Reid K, Kurian T, Sayegh Z, Julia E, Maakaron J, Bachanova V, Jurdi NE, MacMillan ML, Weisdorf DJ, Felices M, Miller JS, Blazar BR, Davila ML, Betts BC. Holtan SG, et al. Among authors: betts bc. Clin Cancer Res. 2023 Mar 14;29(6):1114-1124. doi: 10.1158/1078-0432.CCR-22-2837. Clin Cancer Res. 2023. PMID: 36622700 Free PMC article.
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.
MacDonald KPA, Betts BC, Couriel D. MacDonald KPA, et al. Among authors: betts bc. Biol Blood Marrow Transplant. 2018 Jan;24(1):19-26. doi: 10.1016/j.bbmt.2017.10.006. Epub 2017 Oct 12. Biol Blood Marrow Transplant. 2018. PMID: 29032060 Free article. Review. No abstract available.
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Jurdi NE, Hoover A, O'Leary D, Cao Q, Gupta A, Ebens C, Maakaron JE, Betts BC, Rashidi A, Juckett MB, Lund T, Bachanova V, MacMillan ML, Miller JS, Orchard PJ, Wagner JE, Vercellotti G, Weisdorf DJ, Dusenbery K, Terezakis S, Holtan SG. Jurdi NE, et al. Among authors: betts bc. Transplant Cell Ther. 2023 Sep;29(9):576.e1-576.e5. doi: 10.1016/j.jtct.2023.06.008. Epub 2023 Jun 11. Transplant Cell Ther. 2023. PMID: 37311510 Clinical Trial.
Clarifying the translational potential of B-I09.
Del Valle JR, Betts BC, Yu XZ, Janssens S, Lambrecht BN, Simon MC, Hu CA. Del Valle JR, et al. Among authors: betts bc. Nat Chem Biol. 2020 Nov;16(11):1152. doi: 10.1038/s41589-020-00654-w. Nat Chem Biol. 2020. PMID: 33067597 Free PMC article. No abstract available.
63 results